Peer Review: GSK recruits a star cancer scientist to its board ahead of R&D reorganization
Laurie Glimcher FRANCK FIFE/AFP/Getty
GlaxoSmithKline has just appointed Laurie Glimcher — a pioneering scientist and a champion for advancing women to senior positions in the biomedical world — to its board. Up until just 7 days ago, she was also on the board of Bristol-Myers Squibb, a trendsetter in the blockbuster immuno-oncology world. And the move just may say something about GSK CEO Emma Walmsley’s ideas about the future of the company, which now reportedly include a plan to revamp the pipeline.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.